ADPT — Adaptogenics Health Share Price
Last trade - 00:00- CA$2.37m
- CA$2.35m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -487.77% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | 0 | 0 | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Adaptogenics Health Corp. is a Canada-based nutraceutical company. The Company is focused on the formulation and distribution of functional mushroom products and nutritional supplement alternatives. The Company is focused on developing product formulations combining functional mushrooms and adaptogenic herbs, which support holistic health. Its products include Mushroom Tincture Collection, Chaga Tincture, Cordyceps Tincture, Lion's Mane Tincture and Functional Mushroom Bundle. The Company has also launched its online store on its Website offering its functional mushroom products.
Directors
- Hani Zabaneh COO (52)
- Dave Heel VPR (51)
- Pavandeep Mehat IND (31)
- Martin Bajic IND
- J. David Warren CEO
- Antoun Nabhan PRE (51)
- Steven Nguyen CFO
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- April 1st, 2021
- Public Since
- January 9th, 2023
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 8,186,925
- Address
- 1100 - 1111 Melville Street, VANCOUVER, V6E 3V6
- Web
- https://adaptogenicshealth.com
- Phone
- +1 6047824264
- Auditors
- Crowe MacKay LLP
Similar to ADPT
Affinor Growers
Canadian Securities Exchange
Boosh Plant-based Brands
Canadian Securities Exchange
Britannia Life Sciences
Canadian Securities Exchange
Else Nutrition Holdings
Canadian Securities Exchange
Harrys Manufacturing
Canadian Securities Exchange
FAQ
As of Today at 18:04 UTC, shares in Adaptogenics Health are trading at CA$0.29. This share price information is delayed by 15 minutes.
Shares in Adaptogenics Health last closed at CA$0.29 and the price had moved by +262.5% over the past 365 days. In terms of relative price strength the Adaptogenics Health share price has outperformed the Toronto Stock Exchange 300 Composite Index by +202.97% over the past year.
There is no consensus recommendation for this security.
Find out moreAdaptogenics Health does not currently pay a dividend.
Adaptogenics Health does not currently pay a dividend.
Adaptogenics Health does not currently pay a dividend.
To buy shares in Adaptogenics Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.29, shares in Adaptogenics Health had a market capitalisation of CA$2.37m.
Here are the trading details for Adaptogenics Health:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: ADPT
Based on an overall assessment of its quality, value and momentum Adaptogenics Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adaptogenics Health. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +176.63%.
As of the last closing price of CA$0.29, shares in Adaptogenics Health were trading +125.16% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Adaptogenics Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Adaptogenics Health's management team is headed by:
- Hani Zabaneh - COO
- Dave Heel - VPR
- Pavandeep Mehat - IND
- Martin Bajic - IND
- J. David Warren - CEO
- Antoun Nabhan - PRE
- Steven Nguyen - CFO